A.R.T. Advisors, LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q4 2020$56,000
-46.2%
10,335
-57.1%
0.26%
+4216.7%
Q1 2019$104,000
-89.1%
24,111
-71.6%
0.01%
-84.2%
Q1 2018$953,000
+197.8%
84,925
+116.9%
0.04%
+137.5%
Q3 2017$320,000
+196.3%
39,158
+62.4%
0.02%
+166.7%
Q2 2017$108,000
-41.9%
24,108
-28.6%
0.01%
-33.3%
Q1 2017$186,000
+6.3%
33,773
+56.4%
0.01%
+12.5%
Q1 2016$175,000
-34.0%
21,600
-1.8%
0.01%
-38.5%
Q4 2015$265,00022,0000.01%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q1 2018
NameSharesValueWeighting ↓
NEA Management Company, LLC 15,832,611$68,080,0003.54%
Matrix Capital Management Company, LP 28,000,000$120,400,0003.21%
Virtus ETF Advisers LLC 50,655$218,0000.46%
TFG Asset Management GP Ltd 500,000$2,150,0000.27%
Rock Springs Capital Management LP 800,000$3,440,0000.13%
Orbimed Advisors 1,350,655$5,808,0000.09%
Vident Investment Advisory, LLC 289,340$1,244,0000.07%
WS MANAGEMENT LLLP 185,537$798,0000.05%
Rathbones Group PLC 285,722$1,229,0000.04%
Tekla Capital Management LLC 228,496$983,0000.04%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders